The evolution of personalized cancer genetic counseling in the era of personalized medicine
- PMID: 22419176
- PMCID: PMC3905734
- DOI: 10.1007/s10689-012-9524-8
The evolution of personalized cancer genetic counseling in the era of personalized medicine
Abstract
Practice changes in cancer genetic counseling have occurred to meet the demand for cancer genetic services. As cancer genetics continues to impact not only prevention strategies but also treatment decisions, current cancer genetic counseling models will need to be tailored to accommodate emerging clinical indications. These clinical indications include: surgical prophylactic bilateral mastectomy candidates, PARP-inhibitor candidates, patients with abnormal tumor screening results for Lynch syndrome, and post-test counseling patients (after genetic testing is ordered by another healthcare provider). A more personalized, multidisciplinary approach to selecting the best framework, for a given clinical indication, may become increasingly necessary in this era of personalized medicine.
References
-
- Berliner JL, Fay AM. Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors. J Genet Couns. 2007;16(3):241–260. - PubMed
-
- Trepanier AM. 2007 National Society of Genetic Counselors presidential address: embracing change to race forward. J Genet Couns. 2008;17(1):2–5. - PubMed
-
- Cavalli P. Genetic counseling: a medical approach. Genet Test. 2009 - PubMed
-
- Wham D, Vu T, Chan-Smutko G, Kobelka C, Urbauer D, Heald B. Assessment of clinical practices among cancer genetic counselors. Fam Cancer. 2010;9(3):459–468. - PubMed
-
- Balint J, Shelton W. Regaining the initiative. Forging a new model of the patient-physician relationship. JAMA. 1996;275(11):887–891. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
